Despite steady revenue growth and expanding market adoption, the company faces significant challenges. Operating expenses and losses have increased substantially, raising concerns about financial health. While future expansion plans and product development are promising, the lack of clear guidance on timelines and market entry for new formulations, coupled with increased expenses, suggests uncertainty. The Q&A section reveals management's avoidance of specifics, adding to negative sentiment. Overall, the financial strain and unclear strategic execution overshadow positive growth aspects, likely resulting in a negative stock price reaction.